---
annotation-target: s41597-021-00915-w.pdf
---


>%%
>```annotation-json
>{"created":"2022-09-07T02:11:50.940Z","updated":"2022-09-07T02:11:50.940Z","document":{"title":"DLBCL-Morph: Morphological features computed using deep learning for an annotated digital DLBCL image set","link":[{"href":"urn:x-pdf:bb07e9bbd29cbc51daa2a67912a600e6"},{"href":"vault:/hematology-theroy/papers/20220830andrewng/s41597-021-00915-w.pdf"}],"documentFingerprint":"bb07e9bbd29cbc51daa2a67912a600e6"},"uri":"vault:/hematology-theroy/papers/20220830andrewng/s41597-021-00915-w.pdf","target":[{"source":"vault:/hematology-theroy/papers/20220830andrewng/s41597-021-00915-w.pdf","selector":[{"type":"TextPositionSelector","start":2094,"end":2607},{"type":"TextQuoteSelector","exact":". Currently, the most effective prognostic classification is the National Comprehensive Cancer Network International Prognostic Index (NCCN-IPI), which incorporates five clinical variables including age, lactate dehydrogenase (LDH), extra-nodal sites of involvement, Ann Arbor stage, and ECOG performance status4. The NCCN-IPI model is widely used to risk stratify patients into good, intermediate, and poor-risk categories, how-ever it is insufficient to guide therapeutic decision-making for individual patients","prefix":"l, biologic, and genetic factors","suffix":".Gene expression profiling (GEP)"}]}]}
>```
>%%
>*%%PREFIX%%l, biologic, and genetic factors%%HIGHLIGHT%% ==. Currently, the most effective prognostic classification is the National Comprehensive Cancer Network International Prognostic Index (NCCN-IPI), which incorporates five clinical variables including age, lactate dehydrogenase (LDH), extra-nodal sites of involvement, Ann Arbor stage, and ECOG performance status4. The NCCN-IPI model is widely used to risk stratify patients into good, intermediate, and poor-risk categories, how-ever it is insufficient to guide therapeutic decision-making for individual patients== %%POSTFIX%%.Gene expression profiling (GEP)*
>%%LINK%%[[#^170sdzr4tky|show annotation]]
>%%COMMENT%%
>
>%%TAGS%%
>
^170sdzr4tky


>%%
>```annotation-json
>{"created":"2022-09-07T02:12:51.052Z","updated":"2022-09-07T02:12:51.052Z","document":{"title":"DLBCL-Morph: Morphological features computed using deep learning for an annotated digital DLBCL image set","link":[{"href":"urn:x-pdf:bb07e9bbd29cbc51daa2a67912a600e6"},{"href":"vault:/hematology-theroy/papers/20220830andrewng/s41597-021-00915-w.pdf"}],"documentFingerprint":"bb07e9bbd29cbc51daa2a67912a600e6"},"uri":"vault:/hematology-theroy/papers/20220830andrewng/s41597-021-00915-w.pdf","target":[{"source":"vault:/hematology-theroy/papers/20220830andrewng/s41597-021-00915-w.pdf","selector":[{"type":"TextPositionSelector","start":2608,"end":3370},{"type":"TextQuoteSelector","exact":"Gene expression profiling (GEP) studies revealed distinct subtypes of DLBCL that correspond to differences in cell of origin (COO) and show different outcomes in response to R-CHOP therapy5,6. This approach categorizes DLBCL as either germinal center B-cell (GCB), activated B-cell (ABC), or indeterminate, based on the phase of B-cell development it most closely resembles7. A practical algorithm employing this approach for immunohisto-chemically stained, formalin fixed, paraffin embedded tissue was developed by Hans et al., and despite imperfect concordance with the gold standard GEP method, it is now the most widely used algorithm in the United States for DLBCL8. The GCB subtype is associated with more favorable outcomes than the non-GCB subtype5,9–13.","prefix":"-making for individual patients.","suffix":"In addition to COO subtyping, do"}]}]}
>```
>%%
>*%%PREFIX%%-making for individual patients.%%HIGHLIGHT%% ==Gene expression profiling (GEP) studies revealed distinct subtypes of DLBCL that correspond to differences in cell of origin (COO) and show different outcomes in response to R-CHOP therapy5,6. This approach categorizes DLBCL as either germinal center B-cell (GCB), activated B-cell (ABC), or indeterminate, based on the phase of B-cell development it most closely resembles7. A practical algorithm employing this approach for immunohisto-chemically stained, formalin fixed, paraffin embedded tissue was developed by Hans et al., and despite imperfect concordance with the gold standard GEP method, it is now the most widely used algorithm in the United States for DLBCL8. The GCB subtype is associated with more favorable outcomes than the non-GCB subtype5,9–13.== %%POSTFIX%%In addition to COO subtyping, do*
>%%LINK%%[[#^ve8mbz04lui|show annotation]]
>%%COMMENT%%
>
>%%TAGS%%
>
^ve8mbz04lui


>%%
>```annotation-json
>{"created":"2022-09-07T02:14:04.795Z","updated":"2022-09-07T02:14:04.795Z","document":{"title":"DLBCL-Morph: Morphological features computed using deep learning for an annotated digital DLBCL image set","link":[{"href":"urn:x-pdf:bb07e9bbd29cbc51daa2a67912a600e6"},{"href":"vault:/hematology-theroy/papers/20220830andrewng/s41597-021-00915-w.pdf"}],"documentFingerprint":"bb07e9bbd29cbc51daa2a67912a600e6"},"uri":"vault:/hematology-theroy/papers/20220830andrewng/s41597-021-00915-w.pdf","target":[{"source":"vault:/hematology-theroy/papers/20220830andrewng/s41597-021-00915-w.pdf","selector":[{"type":"TextPositionSelector","start":3370,"end":3692},{"type":"TextQuoteSelector","exact":"In addition to COO subtyping, double-hit lymphomas with concurrent chromosomal translocations of the MYC and BCL2 genes, or less commonly MYC and BCL6 genes, and double-expressor lymphomas with dual overexpres-sion of MYC and BCL2 proteins have been found to correlate with an aggressive clinical course and poor outcomes ","prefix":" than the non-GCB subtype5,9–13.","suffix":"1Department of computer Science,"}]}]}
>```
>%%
>*%%PREFIX%%than the non-GCB subtype5,9–13.%%HIGHLIGHT%% ==In addition to COO subtyping, double-hit lymphomas with concurrent chromosomal translocations of the MYC and BCL2 genes, or less commonly MYC and BCL6 genes, and double-expressor lymphomas with dual overexpres-sion of MYC and BCL2 proteins have been found to correlate with an aggressive clinical course and poor outcomes== %%POSTFIX%%1Department of computer Science,*
>%%LINK%%[[#^vbzmmehzu8|show annotation]]
>%%COMMENT%%
>
>%%TAGS%%
>
^vbzmmehzu8


>%%
>```annotation-json
>{"created":"2022-09-07T02:14:46.387Z","updated":"2022-09-07T02:14:46.387Z","document":{"title":"DLBCL-Morph: Morphological features computed using deep learning for an annotated digital DLBCL image set","link":[{"href":"urn:x-pdf:bb07e9bbd29cbc51daa2a67912a600e6"},{"href":"vault:/hematology-theroy/papers/20220830andrewng/s41597-021-00915-w.pdf"}],"documentFingerprint":"bb07e9bbd29cbc51daa2a67912a600e6"},"uri":"vault:/hematology-theroy/papers/20220830andrewng/s41597-021-00915-w.pdf","target":[{"source":"vault:/hematology-theroy/papers/20220830andrewng/s41597-021-00915-w.pdf","selector":[{"type":"TextPositionSelector","start":4305,"end":4593},{"type":"TextQuoteSelector","exact":"termination of these molecular subsets is now standard of care per the World Health Organization (WHO) guidelines and patients harboring dual chromosomal translocations are now formally classified as having high grade B-cell lymphoma, with MYC and BCL2 and/or BCL6 translocations (HGBL)15","prefix":"a/when treated with R-CHOP14. De","suffix":".While COO subtyping by the Hans"}]}]}
>```
>%%
>*%%PREFIX%%a/when treated with R-CHOP14. De%%HIGHLIGHT%% ==termination of these molecular subsets is now standard of care per the World Health Organization (WHO) guidelines and patients harboring dual chromosomal translocations are now formally classified as having high grade B-cell lymphoma, with MYC and BCL2 and/or BCL6 translocations (HGBL)15== %%POSTFIX%%.While COO subtyping by the Hans*
>%%LINK%%[[#^bc9iu2jxaym|show annotation]]
>%%COMMENT%%
>
>%%TAGS%%
>
^bc9iu2jxaym


>%%
>```annotation-json
>{"created":"2022-09-07T02:15:24.247Z","updated":"2022-09-07T02:15:24.247Z","document":{"title":"DLBCL-Morph: Morphological features computed using deep learning for an annotated digital DLBCL image set","link":[{"href":"urn:x-pdf:bb07e9bbd29cbc51daa2a67912a600e6"},{"href":"vault:/hematology-theroy/papers/20220830andrewng/s41597-021-00915-w.pdf"}],"documentFingerprint":"bb07e9bbd29cbc51daa2a67912a600e6"},"uri":"vault:/hematology-theroy/papers/20220830andrewng/s41597-021-00915-w.pdf","target":[{"source":"vault:/hematology-theroy/papers/20220830andrewng/s41597-021-00915-w.pdf","selector":[{"type":"TextPositionSelector","start":4769,"end":5269},{"type":"TextQuoteSelector","exact":"n the morphologic properties of the tumor itself has historically been challenging due to the significant histomorphologic heterogeneity of DLBCL. Cytologically, DLBCL may resemble centroblasts with multiple peripheral nucleoli and vesicular chromatin or immunoblasts with abundant cytoplasm and a single prominent nucleolus. However, the prognostic significance of these and other recognised cytologic variants, for example anaplastic type DLBCL, is unclear and the subject of continued debate16–21.","prefix":" B-cells, classification based o","suffix":"Though several studies have thus"}]}]}
>```
>%%
>*%%PREFIX%%B-cells, classification based o%%HIGHLIGHT%% ==n the morphologic properties of the tumor itself has historically been challenging due to the significant histomorphologic heterogeneity of DLBCL. Cytologically, DLBCL may resemble centroblasts with multiple peripheral nucleoli and vesicular chromatin or immunoblasts with abundant cytoplasm and a single prominent nucleolus. However, the prognostic significance of these and other recognised cytologic variants, for example anaplastic type DLBCL, is unclear and the subject of continued debate16–21.== %%POSTFIX%%Though several studies have thus*
>%%LINK%%[[#^l23e5dvyqgs|show annotation]]
>%%COMMENT%%
>
>%%TAGS%%
>
^l23e5dvyqgs


>%%
>```annotation-json
>{"created":"2022-09-07T02:16:20.396Z","updated":"2022-09-07T02:16:20.396Z","document":{"title":"DLBCL-Morph: Morphological features computed using deep learning for an annotated digital DLBCL image set","link":[{"href":"urn:x-pdf:bb07e9bbd29cbc51daa2a67912a600e6"},{"href":"vault:/hematology-theroy/papers/20220830andrewng/s41597-021-00915-w.pdf"}],"documentFingerprint":"bb07e9bbd29cbc51daa2a67912a600e6"},"uri":"vault:/hematology-theroy/papers/20220830andrewng/s41597-021-00915-w.pdf","target":[{"source":"vault:/hematology-theroy/papers/20220830andrewng/s41597-021-00915-w.pdf","selector":[{"type":"TextPositionSelector","start":5269,"end":5541},{"type":"TextQuoteSelector","exact":"Though several studies have thus far failed to conclusively demonstrate that morphologic classification can predict outcomes in DLBCL, automated imaging methods could potentially identify novel, prognostically signifi-cant morphological or immunohistochemical biomarkers. ","prefix":"ubject of continued debate16–21.","suffix":"The ability of automated methods"}]}]}
>```
>%%
>*%%PREFIX%%ubject of continued debate16–21.%%HIGHLIGHT%% ==Though several studies have thus far failed to conclusively demonstrate that morphologic classification can predict outcomes in DLBCL, automated imaging methods could potentially identify novel, prognostically signifi-cant morphological or immunohistochemical biomarkers.== %%POSTFIX%%The ability of automated methods*
>%%LINK%%[[#^gzt28snsgu|show annotation]]
>%%COMMENT%%
>
>%%TAGS%%
>
^gzt28snsgu


>%%
>```annotation-json
>{"created":"2022-09-07T02:16:46.512Z","updated":"2022-09-07T02:16:46.512Z","document":{"title":"DLBCL-Morph: Morphological features computed using deep learning for an annotated digital DLBCL image set","link":[{"href":"urn:x-pdf:bb07e9bbd29cbc51daa2a67912a600e6"},{"href":"vault:/hematology-theroy/papers/20220830andrewng/s41597-021-00915-w.pdf"}],"documentFingerprint":"bb07e9bbd29cbc51daa2a67912a600e6"},"uri":"vault:/hematology-theroy/papers/20220830andrewng/s41597-021-00915-w.pdf","target":[{"source":"vault:/hematology-theroy/papers/20220830andrewng/s41597-021-00915-w.pdf","selector":[{"type":"TextPositionSelector","start":5871,"end":6109},{"type":"TextQuoteSelector","exact":" A critical requirement for the development of these models is the availability of datasets containing digitally scanned slides stained to show cell morphology and expression of relevant proteins with accompanying prognostic outcome data.","prefix":"y costly and/or labor intensive.","suffix":"Here we present DLBCL-Morph, a p"}]}]}
>```
>%%
>*%%PREFIX%%y costly and/or labor intensive.%%HIGHLIGHT%% ==A critical requirement for the development of these models is the availability of datasets containing digitally scanned slides stained to show cell morphology and expression of relevant proteins with accompanying prognostic outcome data.== %%POSTFIX%%Here we present DLBCL-Morph, a p*
>%%LINK%%[[#^p05s9gn7wcl|show annotation]]
>%%COMMENT%%
>
>%%TAGS%%
>
^p05s9gn7wcl


>%%
>```annotation-json
>{"created":"2022-09-07T02:22:10.683Z","updated":"2022-09-07T02:22:10.683Z","document":{"title":"DLBCL-Morph: Morphological features computed using deep learning for an annotated digital DLBCL image set","link":[{"href":"urn:x-pdf:bb07e9bbd29cbc51daa2a67912a600e6"},{"href":"vault:/hematology-theroy/papers/20220830andrewng/s41597-021-00915-w.pdf"}],"documentFingerprint":"bb07e9bbd29cbc51daa2a67912a600e6"},"uri":"vault:/hematology-theroy/papers/20220830andrewng/s41597-021-00915-w.pdf","target":[{"source":"vault:/hematology-theroy/papers/20220830andrewng/s41597-021-00915-w.pdf","selector":[{"type":"TextPositionSelector","start":6380,"end":6826},{"type":"TextQuoteSelector","exact":"All of the TMAs are accompanied by pathologist-annotated regions-of-interest (ROIs) that indicate areas representative of DLBCL. For each patient in the dataset, we provide survival data, follow-up status, and a wide range of clinical and molecular variables such as age and MYC/BCL2/BCL6 gene translocations. We also segmented out tumor nuclei from ROIs inside the H&E stained TMAs, and provide several geometric features for each tumor nucleus.","prefix":"L2, and MYC protein expression. ","suffix":"MethodsOur dataset contains digi"}]}]}
>```
>%%
>*%%PREFIX%%L2, and MYC protein expression.%%HIGHLIGHT%% ==All of the TMAs are accompanied by pathologist-annotated regions-of-interest (ROIs) that indicate areas representative of DLBCL. For each patient in the dataset, we provide survival data, follow-up status, and a wide range of clinical and molecular variables such as age and MYC/BCL2/BCL6 gene translocations. We also segmented out tumor nuclei from ROIs inside the H&E stained TMAs, and provide several geometric features for each tumor nucleus.== %%POSTFIX%%MethodsOur dataset contains digi*
>%%LINK%%[[#^0f0kwpsk7uh|show annotation]]
>%%COMMENT%%
>
>%%TAGS%%
>
^0f0kwpsk7uh
